Stem cells as a potential therapy for diabetes mellitus

A call-to-action in Latin America

Mairim Alexandra Solis, Ilais Moreno Velásquez, Ricardo Correa, Lynn Ling-Huei Huang

Research output: Contribution to journalReview article

Abstract

Latin America is a fast-growing region that currently faces unique challenges in the treatment of all forms of diabetes mellitus. The burden of this disease will be even greater in the coming years due, in part, to the large proportion of young adults living in urban areas and engaging in unhealthy lifestyles. Unfortunately, the national health systems in Latin-American countries are unprepared and urgently need to reorganize their health care services to achieve diabetic therapeutic goals. Stem cell research is attracting increasing attention as a promising and fast-growing field in Latin America. As future healthcare systems will include the development of regenerative medicine through stem cell research, Latin America is urged to issue a call-to-action on stem cell research. Increased efforts are required in studies focused on stem cells for the treatment of diabetes. In this review, we aim to inform physicians, researchers, patients and funding sources about the advances in stem cell research for possible future applications in diabetes mellitus. Emerging studies are demonstrating the potential of stem cells for β cell differentiation and pancreatic regeneration. The major economic burden implicated in patients with diabetes complications suggests that stem cell research may relieve diabetic complications. Closer attention should be paid to stem cell research in the future as an alternative treatment for diabetes mellitus.

Original languageEnglish
Article number20
JournalDiabetology and Metabolic Syndrome
Volume11
Issue number1
DOIs
Publication statusPublished - 2019 Feb 18

Fingerprint

Stem Cell Research
Latin America
Diabetes Mellitus
Stem Cells
Diabetes Complications
Therapeutics
Delivery of Health Care
Regenerative Medicine
Health Services
Life Style
Regeneration
Cell Differentiation
Young Adult
Economics
Research Personnel
Physicians
Health

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Solis, Mairim Alexandra ; Moreno Velásquez, Ilais ; Correa, Ricardo ; Huang, Lynn Ling-Huei. / Stem cells as a potential therapy for diabetes mellitus : A call-to-action in Latin America. In: Diabetology and Metabolic Syndrome. 2019 ; Vol. 11, No. 1.
@article{d3eef6bbf77d4eaa96b076b1ba1cd708,
title = "Stem cells as a potential therapy for diabetes mellitus: A call-to-action in Latin America",
abstract = "Latin America is a fast-growing region that currently faces unique challenges in the treatment of all forms of diabetes mellitus. The burden of this disease will be even greater in the coming years due, in part, to the large proportion of young adults living in urban areas and engaging in unhealthy lifestyles. Unfortunately, the national health systems in Latin-American countries are unprepared and urgently need to reorganize their health care services to achieve diabetic therapeutic goals. Stem cell research is attracting increasing attention as a promising and fast-growing field in Latin America. As future healthcare systems will include the development of regenerative medicine through stem cell research, Latin America is urged to issue a call-to-action on stem cell research. Increased efforts are required in studies focused on stem cells for the treatment of diabetes. In this review, we aim to inform physicians, researchers, patients and funding sources about the advances in stem cell research for possible future applications in diabetes mellitus. Emerging studies are demonstrating the potential of stem cells for β cell differentiation and pancreatic regeneration. The major economic burden implicated in patients with diabetes complications suggests that stem cell research may relieve diabetic complications. Closer attention should be paid to stem cell research in the future as an alternative treatment for diabetes mellitus.",
author = "Solis, {Mairim Alexandra} and {Moreno Vel{\'a}squez}, Ilais and Ricardo Correa and Huang, {Lynn Ling-Huei}",
year = "2019",
month = "2",
day = "18",
doi = "10.1186/s13098-019-0415-0",
language = "English",
volume = "11",
journal = "Diabetology and Metabolic Syndrome",
issn = "1758-5996",
publisher = "BioMed Central",
number = "1",

}

Stem cells as a potential therapy for diabetes mellitus : A call-to-action in Latin America. / Solis, Mairim Alexandra; Moreno Velásquez, Ilais; Correa, Ricardo; Huang, Lynn Ling-Huei.

In: Diabetology and Metabolic Syndrome, Vol. 11, No. 1, 20, 18.02.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Stem cells as a potential therapy for diabetes mellitus

T2 - A call-to-action in Latin America

AU - Solis, Mairim Alexandra

AU - Moreno Velásquez, Ilais

AU - Correa, Ricardo

AU - Huang, Lynn Ling-Huei

PY - 2019/2/18

Y1 - 2019/2/18

N2 - Latin America is a fast-growing region that currently faces unique challenges in the treatment of all forms of diabetes mellitus. The burden of this disease will be even greater in the coming years due, in part, to the large proportion of young adults living in urban areas and engaging in unhealthy lifestyles. Unfortunately, the national health systems in Latin-American countries are unprepared and urgently need to reorganize their health care services to achieve diabetic therapeutic goals. Stem cell research is attracting increasing attention as a promising and fast-growing field in Latin America. As future healthcare systems will include the development of regenerative medicine through stem cell research, Latin America is urged to issue a call-to-action on stem cell research. Increased efforts are required in studies focused on stem cells for the treatment of diabetes. In this review, we aim to inform physicians, researchers, patients and funding sources about the advances in stem cell research for possible future applications in diabetes mellitus. Emerging studies are demonstrating the potential of stem cells for β cell differentiation and pancreatic regeneration. The major economic burden implicated in patients with diabetes complications suggests that stem cell research may relieve diabetic complications. Closer attention should be paid to stem cell research in the future as an alternative treatment for diabetes mellitus.

AB - Latin America is a fast-growing region that currently faces unique challenges in the treatment of all forms of diabetes mellitus. The burden of this disease will be even greater in the coming years due, in part, to the large proportion of young adults living in urban areas and engaging in unhealthy lifestyles. Unfortunately, the national health systems in Latin-American countries are unprepared and urgently need to reorganize their health care services to achieve diabetic therapeutic goals. Stem cell research is attracting increasing attention as a promising and fast-growing field in Latin America. As future healthcare systems will include the development of regenerative medicine through stem cell research, Latin America is urged to issue a call-to-action on stem cell research. Increased efforts are required in studies focused on stem cells for the treatment of diabetes. In this review, we aim to inform physicians, researchers, patients and funding sources about the advances in stem cell research for possible future applications in diabetes mellitus. Emerging studies are demonstrating the potential of stem cells for β cell differentiation and pancreatic regeneration. The major economic burden implicated in patients with diabetes complications suggests that stem cell research may relieve diabetic complications. Closer attention should be paid to stem cell research in the future as an alternative treatment for diabetes mellitus.

UR - http://www.scopus.com/inward/record.url?scp=85061897872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061897872&partnerID=8YFLogxK

U2 - 10.1186/s13098-019-0415-0

DO - 10.1186/s13098-019-0415-0

M3 - Review article

VL - 11

JO - Diabetology and Metabolic Syndrome

JF - Diabetology and Metabolic Syndrome

SN - 1758-5996

IS - 1

M1 - 20

ER -